Clinical trial registry record

Myocardial Fibrosis, Function and Aging

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated March 12, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT03064503
Last registry update
March 12, 2026
Status
Completed
Phase
Phase not reported
Sponsor
Hospices Civils de Lyon
Enrollment
74
Countries
France
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
NA · SINGLE GROUP · BASIC SCIENCE · NONE
Evidence population
Human clinical study registration
Participants
74
Population
ALL · 18 Years
Duration
2017-02-20 to 2023-12-05
Intervention
Blood sampling; MRI; Skin auto-fluorescence
Comparator
Not reported
Outcomes measured
Regional myocardial strain — The day of MRI; MRI T1 value — The day of MRI, before gadolinium injection; MRI T1 value — The day of MRI, 15 minutes after gadolinium injection; Apparent Diffusion Coefficient (ADC) with MRI — The day of MRI; Blood carboxy-terminal propeptide of procollagen type I (PICP) rate — The day of MRI; Blood amino-terminal propeptide of procollagen type III (PIIINP) rate — The day of MRI; Advanced Glycation End-products (AGE) rate — The day of MRI
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Extracellular matrix ageing · 100%Title contains controlled term: fibrosis. Abstract contains controlled term: fibrosis. Title supplies longevity context: aging. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.

extracellular matrix aging
Open primary sourceExport JSON